Blog
Latest articles, insights, and updates from the blog.
Contact Ketamine Tablet
Send corrections, provider questions, or advertising inquiries.
Food & Antacids: How They Affect Oral Ketamine Absorption
Learn how food, antacids, and stomach pH affect oral ketamine tablet absorption. Timing guidelines for better bioavailability.
Boston Clinics Spotlight Ketamine's Mental Health Role
Boston health clinics are expanding ketamine therapy for depression and PTSD — here's what it means for patients exploring oral ketamine tablets.
One Patient's Year With Ketamine and Experimental Care
A Guardian journalist tried ketamine and other cutting-edge depression treatments for a year. What oral ketamine patients can learn from her experience.
Study: CBT After Ketamine Cuts Depression Relapse Risk
The CBT-ENDURE trial shows adding 16 weeks of CBT to esketamine outperforms ketamine alone for depression and suicidal ideation.
Ketamine for PTSD: Workers' Comp Coverage Is Shifting
Alabama workers' comp rulings on ketamine for PTSD and depression signal a broader coverage shift. Here's what it means for oral ketamine tablet patients.
Your Antidepressant Class May Not Affect Ketamine Results
New research shows concurrent SSRI, SNRI, or other antidepressant use doesn't significantly alter ketamine outcomes — what oral ketamine tablet users need to know.
How Symptom Tracking Reshapes Oral Ketamine Dosing for TRD
Regular symptom tracking and faster dose adjustments drive TRD remission sooner. Here's what that means for oral ketamine tablet users.
NMDA Antagonist Side Effects: What Tablet Users Need to Know
New clinical data on NMDA antagonist side effects and dropout rates has real implications for oral ketamine tablet users. Here's what the research means for you.
FDA Signals Support for Preservative-Free Ketamine
The FDA has issued a positive response on preservative-free ketamine formulations. Here's what this regulatory shift means for oral ketamine tablet patients.
Why Patients Quit Ketamine Early—And How Tablets Factor In
New clinical data on NMDA antagonist dropout rates reveals how side effect management and route of administration affect treatment-resistant depression outcomes.
TRD Guidelines Spotlight Ketamine's Growing Role
Psychiatric Times highlights optimizing TRD treatments in 2026. Here's what it means for patients using oral ketamine tablets for depression.
Oral Ketamine Side Effects: What New TRD Data Tells Us
New clinical guidance on NMDA antagonist side effects and discontinuation rates offers key lessons for oral ketamine tablet users managing treatment-resistant depression.
NRx's Preservative-Free Ketamine Moves Closer to FDA OK
NRx Pharmaceuticals reports progress on its FDA application for preservative-free ketamine. Here's what this could mean for tablets, dosing, and patient access.